Clinical Trial: Screening Early Diagnostic Biomarkers for Amyotrophic Lateral Sclerosis Based on Multi-Omics Technologies and the Establishment and Application Evaluation of a Highly Sensitive Detection System (China)

Posted On: 2026-08-24

China, Aug. 24 -- The Chinese Clinical Trial Registry (ChiCTR) received information related to the study titled 'Screening Early Diagnostic Biomarkers for Amyotrophic Lateral Sclerosis Based on Multi-Omics Technologies and the Establishment and Application Evaluation of a Highly Sensitive Detection System'. The following are the other relevant details related to the trial:

Registration Number: ChiCTR2600130641

Registration Time: 2026/08/23

Type: Observational study

Primary Sponsor: The First Medical Center of the People's Liberation Army General Hospital

To know more, click on https://www.chictr.org.cn/showprojEN.html?proj=337603

Published by HT Digital Content Services with permission from Health Daily Digest....

Click here to read full article from source

To read the full article or to get the complete feed from this publication, please Contact Us.

Exclusive

Category

Source

Publication

Location

Clinical Trial: Screening Early Diagnostic Biomarkers for Amyotrophic Lateral Sclerosis Based on Multi-Omics Technologies and the Establishment and Application Evaluation of a Highly Sensitive Detection System (China)